Department of Obstetrics and Gynecology, Daping Hospital, Army Medical University (Third Military Medical University), No. 10 Changjiang Branch Road, Yuzhong District, Chongqing, China.
Department of Obstetrics and Gynecology, Affiliated Hospital of the NCO School of Army Medical University (Third Military Medical University), Shijiazhuang, 050000, China.
Hum Cell. 2024 Sep;37(5):1446-1461. doi: 10.1007/s13577-024-01104-8. Epub 2024 Jul 16.
Cervical cancer poses a significant health burden for women globally, and the rapid proliferation of cervical cancer cells greatly worsens patient prognosis. Long non-coding RNAs (lncRNAs) play a crucial role in regulating tumor cell proliferation. However, the involvement of lncRNAs in cervical cancer cell proliferation remains unclear. In this study, we investigated the lncRNA SIX1-1, which was found to be upregulated in cervical cancer tissues and cell lines. Functional assays revealed that knockdown of SIX1-1 inhibited cell proliferation in vitro and reduced tumor growth in vivo. Mechanistically, SIX1-1 was predominantly localized in the nucleus and could bind with DNMT1 protein. The expression of SIX1-1 enhanced the interaction of DNMT1 with RASD1 promoter, leading to the methylation of the promoter and decreased mRNA transcription. Then RASD1 downregulation activated the cAMP/PKA/CREB signaling pathway, promoting cell proliferation. Rescue experiments showed that knockdown of RASD1 restored the inhibited cell proliferation caused by decreased expression of SIX1-1, indicating that RASD1 acted as the functional mediator of SIX1-1. In conclusion, SIX1-1 promoted cervical cancer cell proliferation by modulating RASD1 expression. This suggests that targeting the SIX1-1/RASD1 axis could be a potential antitumor strategy for cervical cancer.
宫颈癌对全球女性健康构成重大负担,而宫颈癌细胞的快速增殖极大地恶化了患者的预后。长链非编码 RNA(lncRNA)在调节肿瘤细胞增殖中起着至关重要的作用。然而,lncRNA 参与宫颈癌细胞增殖的机制尚不清楚。在本研究中,我们研究了 lncRNA SIX1-1,发现其在宫颈癌组织和细胞系中上调。功能分析显示,SIX1-1 的敲低抑制了体外细胞增殖,并减少了体内肿瘤生长。机制上,SIX1-1 主要定位于细胞核内,并能与 DNMT1 蛋白结合。SIX1-1 的表达增强了 DNMT1 与 RASD1 启动子的相互作用,导致启动子甲基化和 mRNA 转录减少。然后,RASD1 的下调激活了 cAMP/PKA/CREB 信号通路,促进细胞增殖。挽救实验表明,RASD1 的敲低恢复了 SIX1-1 表达降低引起的抑制细胞增殖,表明 RASD1 作为 SIX1-1 的功能介体发挥作用。总之,SIX1-1 通过调节 RASD1 的表达促进宫颈癌细胞增殖。这表明靶向 SIX1-1/RASD1 轴可能是宫颈癌的一种潜在的抗肿瘤策略。